Alcohol Use Disorder Pharmacotherapy in Patients With Alcohol-Related Liver Disease: A Scoping Review. [PDF]
Jogendran M, Huynh L, Flemming JA.
europepmc +1 more source
Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease. [PDF]
Eun JR, Kim SU.
europepmc +1 more source
Outcomes for patients with alcohol-related liver disease admitted to Scottish intensive care units 2010-2018. [PDF]
Shariff A +4 more
europepmc +1 more source
Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trial. [PDF]
Cook A +19 more
europepmc +1 more source
Association between serum homocysteine levels and advanced hepatic fibrosis in alcohol-related liver disease: A cross-sectional study of NHANES. [PDF]
Ma C, Zhang X, Zhang W, Duan J, Yang H.
europepmc +1 more source
Lipidomic analysis of alcohol use disorder patients revealed the biomarkers for alcohol-related liver disease susceptibility. [PDF]
Wang D, Zhang H, Tang Y.
europepmc +1 more source
Pharmacological therapies for alcohol use disorder reduce hepatic decompensation & mortality in alcohol-related liver disease: A GRADE evaluation through a meta-analysis. [PDF]
Prasad M, Varshney M, Aggarwal P.
europepmc +1 more source
Oxidative stress in a cellular model of alcohol-related liver disease: protection using curcumin nanoformulations. [PDF]
Petagine L +5 more
europepmc +1 more source
Association of life's essential 8 with mortalities in patients with alcohol-related liver disease. [PDF]
Zhang X +5 more
europepmc +1 more source

